194 related articles for article (PubMed ID: 7891351)
1. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.
Joseph DB; Bidlack JM
J Pharmacol Exp Ther; 1995 Mar; 272(3):970-6. PubMed ID: 7891351
[TBL] [Abstract][Full Text] [Related]
2. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
Lawrence DM; Bidlack JM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
[TBL] [Abstract][Full Text] [Related]
3. Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling.
Lawrence DM; Joseph DB; Bidlack JM
Biochem Pharmacol; 1995 Jan; 49(1):81-9. PubMed ID: 7840787
[TBL] [Abstract][Full Text] [Related]
4. Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activity.
Martin-Kleiner I; Bidlack JM
Int Immunopharmacol; 2001 Jan; 1(1):13-20. PubMed ID: 11367510
[TBL] [Abstract][Full Text] [Related]
5. Differential agonist regulation of the human kappa-opioid receptor.
Blake AD; Bot G; Li S; Freeman JC; Reisine T
J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509
[TBL] [Abstract][Full Text] [Related]
6. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
7. kappa-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments.
Avidor-Reiss T; Zippel R; Levy R; Saya D; Ezra V; Barg J; Matus-Leibovitch N; Vogel Z
FEBS Lett; 1995 Mar; 361(1):70-4. PubMed ID: 7890042
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T
J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192
[TBL] [Abstract][Full Text] [Related]
9. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
Shukla VK; Turndorf H; Bansinath M
Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
[TBL] [Abstract][Full Text] [Related]
10. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
11. Relationship between kappa 1 opioid receptor binding and inhibition of adenylyl cyclase in guinea pig brain membranes.
Konkoy CS; Childers SR
Biochem Pharmacol; 1993 Jan; 45(1):207-16. PubMed ID: 8381004
[TBL] [Abstract][Full Text] [Related]
12. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
Zhang WM; Wang HX; Xia Q; Wong TM
Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts.
Xia Q; Sheng JZ; Tai KK; Wong TM
J Pharmacol Exp Ther; 1994 Feb; 268(2):930-4. PubMed ID: 8114007
[TBL] [Abstract][Full Text] [Related]
16. Supersensitization of the adenylyl cyclase system in Chinese hamster ovary cells co-expressing cloned opioid receptors and Gz, a PTX-insensitive G protein.
Ozawa T; Nakagawa T; Minami M; Satoh M
Neurosci Lett; 1999 May; 267(2):117-20. PubMed ID: 10400226
[TBL] [Abstract][Full Text] [Related]
17. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
[TBL] [Abstract][Full Text] [Related]
18. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors.
Yu XC; Li HY; Wang HX; Wong TM
J Mol Cell Cardiol; 1998 Feb; 30(2):405-13. PubMed ID: 9515017
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of the adenylyl cyclase system in cloned kappa-opioid receptor-transfected cells following sustained agonist treatment: A chimeric study using G protein alpha(i)2/alpha(q) subunits.
Nakagawa T; Ozawa T; Watanabe T; Minami M; Satoh M
Jpn J Pharmacol; 1999 Dec; 81(4):353-61. PubMed ID: 10669040
[TBL] [Abstract][Full Text] [Related]
20. kappa-Opioid binding sites on a murine lymphoma cell line.
Bidlack JM; Saripalli LD; Lawrence DM
Eur J Pharmacol; 1992 Nov; 227(3):257-65. PubMed ID: 1335414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
